Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05134155 · ClinicalTrials.gov registry record
A Pilot Study to Test the Acceptability and Feasibility of Relaxation Rooms to Help Reduce Occupational Stress Among Healthcare Workers
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 86
- Enrollment target
NCT05134155: Completed study, sponsored by Mayo Clinic.
NCT05134155 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05134155 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
Test the acceptability and feasibility of a relaxation room to reduce work stress among clinicians and collect clinician-reported outcome data after using the relaxation room.
Primary Outcome
the proportion of clinicians who found the MindBreaks room to be somewhat acceptable or acceptable
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2022-02-26 |
| Est. Completion | 2022-10-27 |
What the finished NCT05134155 record still lists
NCT05134155 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05134155 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05134155 about?
NCT05134155 is a clinical study titled "A Pilot Study to Test the Acceptability and Feasibility of Relaxation Rooms to Help Reduce Occupational Stress Among Healthcare Workers". Test the acceptability and feasibility of a relaxation room to reduce work stress among clinicians and collect clinician-reported outcome data after using the relaxation room.
What is the current status of trial NCT05134155?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2022-02-26. Estimated completion is 2022-10-27.
Who is sponsoring clinical trial NCT05134155?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI